Search Within

Hematology-Oncology Fellows

  1. "Monica Chen"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (8)
  3. Review (3)
  4. Research Letter (2)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. GME, Medicine (29)
  2. Graduate Medical Education (29)
  3. Melanoma Disease Management Team (29)
  4. Department of Medicine (28)
  5. Solid Tumor Oncology Division (28)
  6. Thoracic Oncology (25)

More Groups

People
  1. Monica Chen (29)
  2. Alexander Drilon (16)
  3. Mark Kris (12)
  4. Helena Yu (9)
  5. Clare Wilhelm (7)
  6. Soo Ryum Yang (7)

More People

Years
  1. 2025 (2)
  2. 2024 (15)
  3. 2023 (12)
Publications
  1. Journal of Clinical Oncology (8)
  2. Journal of Thoracic Oncology (6)
  3. Annals of Oncology (3)
  4. JCO Precision Oncology (3)
  5. JAMA Oncology (2)
  6. Annual Review of Cancer Biology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Elsevier Inc. (6)
  3. Oxford University Press (3)
  4. American Association for Cancer Research (2)
  5. American Medical Association (2)
  6. Adis International Ltd (1)

More Publishers

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intracranial outcomes of ipilimumab and nivolumab in melanoma brain metastases after progression on anti-PD-1 therapy
    Research Letter

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Chen, M. F.; Momtaz, P.; Shoushtari, A. N.; Panageas, K. S.; Postow, M. A.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Next-generation sequencing for HLA genotype screening and matching to HLA-restricted therapies
    Research Letter

    Gormally, M. V.; Chen, M. F.; Noronha, A. M.; Panageas, K.; Reynolds, M.; Kohlasch, K.; Novak, B.; Kee-Velez, T.; Clarke, N.; Eubank, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • First-line immunotherapy versus BRAF and MEK inhibitors for patients with BRAF V600E mutant metastatic non-small cell lung cancer
    Meeting Abstract

    Di Federico, A.; Chen, M. F.; Pagliaro, A.; Ogliari, F. R.; Stockhammer, P.; Aldea, M.; Grant, M.; De Giglio, A.; Alessi, J. V.; Pecci, F.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Reply to comment on “Brief report: Tyrosine kinase inhibitors for lung cancers that inhibit MATE-1 can lead to ‘false’ decreases in renal function”
    Correspondence

    Chen, M. F.; Wilhelm, C.; Drilon, A.; Gutgarts, V.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • RET inhibitors in RET fusion-positive lung cancers: Past, present, and future
    Review

    Chen, M. F.; Repetto, M.; Wilhelm, C.; Drilon, A.
    Drugs (2024)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets
    Journal Article

    Chen, M. F.; Yang, S. R.; Tao, J. J.; Desilets, A.; Diamond, E. L.; Wilhelm, C.; Rosen, E.; Gong, Y.; Mullaney, K.; Torrisi, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma
    Meeting Abstract

    Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Das, J. P.; Lezcano, C.; Nair, S.; Lochrin, S. E.; Chen, M. F.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Standardizing radiologic reporting of response to improve the patient experience: Comparing response categories of RECIST 1.1 and a novel, real-world, standardized, oncologic response lexicon derived from clinical radiology reports
    Meeting Abstract

    Chen, M. F.; Ma, W.; Caravella, B. A.; Harada, G.; Gangai, N.; Grimaldi, G.; Waksmundzki, A.; Trevenen, W.; Kohlasch, K.; Reynolds, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Osimertinib, platinum, etoposide as initial treatment for patients with EGFR mutant lung cancers with TP53 and RB1 alterations
    Meeting Abstract

    Chen, M. F.; Rakhade, S.; Quintanal-Villalonga, A.; Lee, J.; Forsythe, B.; Moses, K. A.; Ahn, L. S. H.; Pupo, A.; Falcon, C. J.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save